The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R, Gingras D, Kruger EA, Lamy S, Sirois P, Simard B, Sirois MG, Tranqui L, Baffert F, Beaulieu E, Dimitriadou V, Pépin MC, Courjal F, Ricard I, Poyet P, Falardeau P, Figg WD, Dupont E.
Béliveau R, et al. Among authors: poyet p.
Clin Cancer Res. 2002 Apr;8(4):1242-50.
Clin Cancer Res. 2002.
PMID: 11948139